The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
M Yamamoto, TW Kensler… - Physiological …, 2018 - journals.physiology.org
The Kelch-like ECH-associated protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system
forms the major node of cellular and organismal defense against oxidative and electrophilic …
forms the major node of cellular and organismal defense against oxidative and electrophilic …
NRF2 addiction in cancer cells
H Kitamura, H Motohashi - Cancer science, 2018 - Wiley Online Library
The Kelch‐like ECH‐associated protein 1/nuclear factor erythroid‐derived 2‐like 2 (KEAP 1‐
NRF 2) system is a pivotal defense mechanism against oxidative and electrophilic stress …
NRF 2) system is a pivotal defense mechanism against oxidative and electrophilic stress …
Roles of Nrf2 in cell proliferation and differentiation
S Murakami, H Motohashi - Free Radical Biology and Medicine, 2015 - Elsevier
Abstract The Keap1-Nrf2 system plays pivotal roles in defense mechanisms by regulating
cellular redox homeostasis. Nrf2 is an inducible transcription factor that activates a battery of …
cellular redox homeostasis. Nrf2 is an inducible transcription factor that activates a battery of …
Normal and pathological NRF2 signalling in the central nervous system
T Heurtaux, DS Bouvier, A Benani, S Helgueta Romero… - Antioxidants, 2022 - mdpi.com
The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master
regulator of antioxidant cellular response, but in the time since, numerous important …
regulator of antioxidant cellular response, but in the time since, numerous important …
Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
K Okazaki, H Anzawa, Z Liu, N Ota, H Kitamura… - Nature …, 2020 - nature.com
Transcriptional dysregulation, which can be caused by genetic and epigenetic alterations, is
a fundamental feature of many cancers. A key cytoprotective transcriptional activator, NRF2 …
a fundamental feature of many cancers. A key cytoprotective transcriptional activator, NRF2 …
Mitochondrial metabolism in carcinogenesis and cancer therapy
H Moindjie, S Rodrigues-Ferreira, C Nahmias - Cancers, 2021 - mdpi.com
Simple Summary Reprogramming metabolism is a hallmark of cancer. Warburg's effect,
defined as increased aerobic glycolysis at the expense of mitochondrial respiration in …
defined as increased aerobic glycolysis at the expense of mitochondrial respiration in …
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma
P Pölönen, A Jawahar Deen, HM Leinonen… - Oncogene, 2019 - nature.com
Accumulating evidence suggests that constitutively active Nrf2 has a pivotal role in cancer
as it induces pro-survival genes that promote cancer cell proliferation and chemoresistance …
as it induces pro-survival genes that promote cancer cell proliferation and chemoresistance …
“NRF2 addiction” in lung cancer cells and its impact on cancer therapy
Nuclear factor erythroid 2-like factor 2 (NRF2) is a master regulator of the antioxidant
enzymes and the detoxification proteins that play major roles in redox homeostasis …
enzymes and the detoxification proteins that play major roles in redox homeostasis …
Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway
J Wang, H Wang, K Sun, X Wang, H Pan… - Drug design …, 2018 - Taylor & Francis
Background Chrysin, an active natural bioflavonoid, has been proven to protect against
carcinogenesis. However, the role of chrysin in glioblastoma and the potential molecular …
carcinogenesis. However, the role of chrysin in glioblastoma and the potential molecular …
Exploring the role of Nrf2 signaling in glioblastoma multiforme
WA Awuah, AR Toufik, R Yarlagadda, T Mikhailova… - Discover Oncology, 2022 - Springer
Glioblastoma multiforme (GBM) is one of the most aggressive glial cell tumors in adults.
Although current treatment options for GBM offer some therapeutic benefit, median survival …
Although current treatment options for GBM offer some therapeutic benefit, median survival …